Global Human Albumin Market 2016 - Baxter, Grifols Biologicals, Biotest Pharma, Octapharma, CSL Behring, Green Cross Corporation, SK Plasma, Shanghai RAAS

Human serum albumin is the serum albumin found in human blood. It is the most abundant protein in human blood plasma; it constitutes about half of serum protein. It is produced in the liver. It is soluble and monomeric.

Albumin transports hormones, fatty acids, and other compounds, buffers pH, and maintains oncotic pressure, among other functions.

Download sample report at http://www.fiormarkets.com/report-detail/19775/request-sample

Albumin is synthesized in the liver as preproalbumin, which has an N-terminal peptide that is removed before the nascent protein is released from the rough endoplasmic reticulum. The product, proalbumin, is in turn cleaved in the Golgi vesicles to produce the secreted albumin.

The reference range for albumin concentrations in serum is approximately 35 - 50 g/L (3.5 - 5.0 g/dL). It has a serum half-life of approximately 20 days. It has a molecular mass of 66.5 kDa.

The gene for albumin is located on chromosome 4 and mutations in this gene can result in anomalous proteins. The human albumin gene is 16,961 nucleotides long from the putative 'cap' site to the first poly(A) addition site. It is split into 15 exons that are symmetrically placed within the 3 domains thought to have arisen by triplication of a single primordial domain.

This report provides detailed analysis of worldwide markets for Human Albumin from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Human Albumin market and further lays out an analysis of the factors influencing the supply/demand for Human Albumin, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Access full report at http://www.fiormarkets.com/report/global-human-albumin-market-outlook-2016-2021-19775.html

Global Human Albumin Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Human Albumin market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Human Albumin market are Baxter (USA), Grifols Biologicals (USA), Biotest Pharma (Germany), Octapharma (Switzerland), CSL Behring (Switzerland), Green Cross Corporation (Japan), SK Plasma (South Korea), Shanghai RAAS (China), Hualan Bio (China), Yuanda Shuyang (China), Hebei Da‘an (China) , among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Human Albumin industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.